These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 29722658)
21. Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer. Stokes JB; Nolan NJ; Stelow EB; Walters DM; Weiss GR; de Lange EE; Rich TA; Adams RB; Bauer TW Ann Surg Oncol; 2011 Mar; 18(3):619-27. PubMed ID: 21213060 [TBL] [Abstract][Full Text] [Related]
22. Borderline resectable pancreatic cancer: More than an anatomical concept. Petrelli F; Inno A; Barni S; Ghidini A; Labianca R; Falconi M; Reni M; Cascinu S; Dig Liver Dis; 2017 Feb; 49(2):223-226. PubMed ID: 27931968 [TBL] [Abstract][Full Text] [Related]
23. 3rd St. Gallen EORTC Gastrointestinal Cancer Conference: Consensus recommendations on controversial issues in the primary treatment of pancreatic cancer. Lutz MP; Zalcberg JR; Ducreux M; Aust D; Bruno MJ; Büchler MW; Delpero JR; Gloor B; Glynne-Jones R; Hartwig W; Huguet F; Laurent-Puig P; Lordick F; Maisonneuve P; Mayerle J; Martignoni M; Neoptolemos J; Rhim AD; Schmied BM; Seufferlein T; Werner J; van Laethem JL; Otto F Eur J Cancer; 2017 Jul; 79():41-49. PubMed ID: 28460245 [TBL] [Abstract][Full Text] [Related]
24. Effect of neoadjuvant therapy on local recurrence after resection of pancreatic adenocarcinoma. Greer SE; Pipas JM; Sutton JE; Zaki BI; Tsapakos M; Colacchio TA; Gibson JJ; Wiener DC; Ripple GH; Barth RJ J Am Coll Surg; 2008 Mar; 206(3):451-7. PubMed ID: 18308215 [TBL] [Abstract][Full Text] [Related]
25. New developments in the management of borderline resectable pancreatic cancer. Sharma J; Ng J; Goodman MD; Saif MW JOP; 2013 Mar; 14(2):123-5. PubMed ID: 23474551 [TBL] [Abstract][Full Text] [Related]
27. FOLFIRINOX-based neoadjuvant therapy in borderline resectable or unresectable pancreatic cancer: a meta-analytical review of published studies. Petrelli F; Coinu A; Borgonovo K; Cabiddu M; Ghilardi M; Lonati V; Aitini E; Barni S; Pancreas; 2015 May; 44(4):515-21. PubMed ID: 25872127 [TBL] [Abstract][Full Text] [Related]
28. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts. Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495 [TBL] [Abstract][Full Text] [Related]
29. Management of borderline resectable pancreatic adenocarcinoma. Jia Y; Wang TJ; Allendorf J; Saif MW JOP; 2012 Mar; 13(2):147-50. PubMed ID: 22406587 [TBL] [Abstract][Full Text] [Related]
30. Resection of Borderline Resectable and Locally Advanced Pancreatic Adenocarcinomas after Neoadjuvant Chemotherapy. Addeo P; Rosso E; Fuchshuber P; Oussoultzoglou E; De Blasi V; Simone G; Belletier C; Dufour P; Bachellier P Oncology; 2015; 89(1):37-46. PubMed ID: 25766660 [TBL] [Abstract][Full Text] [Related]
31. Intention to treat outcomes among patients with pancreatic cancer treated using International Study Group on Pancreatic Surgery recommended pathways for resectable and borderline resectable disease. Kamarajah SK; Chatzizacharias N; Hodson J; Marcon F; Kalisvaart M; Punia P; Ting Ma Y; Dasari B; Marudanayagam R; Sutcliffe RP; Muiesan P; Mirza DF; Isaac J; Roberts KJ ANZ J Surg; 2021 Jul; 91(7-8):1549-1557. PubMed ID: 33576568 [TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant Hashmi A; Kozick Z; Fluck M; Hunsinger MA; Wild J; Arora TK; Shabahang MM; Blansfield JA Am Surg; 2018 Sep; 84(9):1439-1445. PubMed ID: 30268172 [TBL] [Abstract][Full Text] [Related]
39. [Progress in neoadjuvant and transformation therapy of pancreatic cancer]. Hu DD; Dai MH Zhonghua Wai Ke Za Zhi; 2017 Jan; 55(1):69-72. PubMed ID: 28056259 [TBL] [Abstract][Full Text] [Related]